鄭 詠仁

Medicine & Life Sciences

1. Survival 100%
2. Mouth 92%
3. Squamous Cell Carcinoma 89%
4. Chemoradiotherapy 87%
5. Mouth Neoplasms 71%
6. Neck 69%
7. Hypopharyngeal Neoplasms 67%
8. Monocrotaline 65%
9. Pulmonary Arterial Hypertension 53%
10. Registries 43%
11. Lymphocytes 31%
12. Databases 27%
13. Neoplasms 25%
14. Serum 20%
15. Therapeutics 19%
16. Radiotherapy 19%
17. Head and Neck Neoplasms 12%
18. Retrospective Studies 8%
19. Histology 8%
20. Multivariate Analysis 8%
21. Intraperitoneal Injections 6%
22. Oropharyngeal Neoplasms 6%
23. paxilline 5%
24. Chi-Square Distribution 5%
25. Escin 5%
26. Tongue 5%
27. Palatine Tonsil 5%